Approaches towards fighting the COVID‑19 pandemic (Review).
Tsai SC, Lu CC, Bau DT, Chiu YJ, Yen YT, Hsu YM, Fu CW, Kuo SC, Lo YS, Chiu HY, Juan YN, Tsai FJ, Yang JS.
Tsai SC, et al.
Int J Mol Med. 2021 Jan;47(1):3-22. doi: 10.3892/ijmm.2020.4794. Epub 2020 Nov 20.
Int J Mol Med. 2021.
PMID: 33236131
Free PMC article.
Review.
The causative agent of COVID-19, SARS-CoV-2, is a novel coronavirus strain. To date, remdesivir has been granted emergency use authorization for use in the management of infection. Additionally, several efficient diagnostic tools are being activ …
The causative agent of COVID-19, SARS-CoV-2, is a novel coronavirus strain. To date, remdesivir has been …